DONANEMAB AND THE FUTURE OF ALZHEIMER’S TREATMENT: BETWEEN INNOVATION AND CAUTION. IJITSS 2025, 3 (4(48). https://doi.org/10.31435/ijitss.4(48).2025.4214.